Table 1 |
|||
|
Baseline clinical characteristics of subjects |
|||
|
Groups |
Placebo |
GCE |
EGML |
|
|
|||
|
N (male: female) |
29(15:14) |
29(15:14) |
28(16:12) |
|
Age (y) |
33.80 ± 2.97 |
34.07 ± 2.30 |
34.96 ± 2.42 |
|
Height (cm) |
169.63 ± 2.84 |
167.17 ± 1.58 |
167.95 ± 1.78 |
|
Body weight (kg) |
74.03 ± 3.03 |
71.09 ± 2.06 |
72.34 ± 1.92 |
|
BMI (kg/m2) |
25.53 ± 0.43 |
25.29 ± 0.36 |
25.25 ± 0.37 |
|
Systolic BP (mmHg) |
122.57 ± 4.49 |
125.69 ± 53 |
123.38 ± 4.02 |
|
Diasolic BP (mmHg) |
76.85 ± 2.65 |
74.11 ± 3.66 |
75.45 ± 3.84 |
|
FBG (mg/dL) |
90.04 ± 2.58 |
93.97 ± 3.44 |
88.73 ± 4.07 |
|
Waist (inch) |
33.43 ± 0.69 |
32.43 ± 0.60 |
33.49 ± 0.61 |
|
Hip (inch) |
39.49 ± 0.47 |
39.10 ± 0.42 |
39.54 ± 0.41 |
|
|
|||
|
Values are mean ± S.E.; GCE, Garcinia cambogia extract; EGML, Extract of Glycine max leaves; FBG, fasting blood glucose |
|||
|
Kim et al. Nutrition Journal 2011 10:94 doi:10.1186/1475-2891-10-94 |
|||
